Publications by authors named "Yuichiro Awazu"

Claim this Profile
A
A Case of Postmenopausal Uterine Adenosarcoma With Concomitant Diabetes Mellitus.
Haruko Fujito, Tomoyo Yasui, Yuichiro Awazu, Kazuharu Tanaka, Kenta Oue

Cureus· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Fetal Cleft Lip and Palate Diagnosed by Three-Dimensional Ultrasound During Pregnancy.
Haruko Fujito, Kazuharu Tanaka, Kensaku Nakai, Yuichiro Awazu, Mayu Kurokawa

Cureus· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Fyn expression in predicting the sensitivity to platinum‑based chemotherapy in patients with ovarian serous carcinoma.
Eijiro Uchikura, Takeshi Fukuda, Tomoki Sengiku, Takuya Noda, Yuichiro Awazu

Oncol Lett· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting recurrence in intermediate‑ and high‑risk stage IB‑IIB cervical cancer treated with adjuvant cisplatin and paclitaxel chemotherapy post‑radical hysterectomy: The role of TBX2 expression.
Takuya Noda, Takeshi Fukuda, Eijiro Uchikura, Yuichiro Awazu, Takuma Wada

Oncol Lett· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal‑type mucinous carcinoma of the endometrium showing a polypoidal exophytic form: A case report.
Chiharu Nakano, Takeshi Fukuda, Sayaka Tanaka, Takuya Noda, Eijiro Uchikura, Yuichiro Awazu

Oncol Lett· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLPTM1L expression predicts recurrence of patients with intermediate‑ and high‑risk stage IB‑IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy.
Yuichiro Awazu, Takeshi Fukuda, Takuya Noda, Eijiro Uchikura, Shigenori Nanno

Oncol Lett· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Efficacy and Safety of Bevacizumab for Advanced or Recurrent Müllerian Cancer: A Single-institutional Experience.
Takeshi Fukuda, Takuya Noda, Eijiro Uchikura, Yuichiro Awazu, Reiko Tasaka

Anticancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fyn expression is associated with the response of patients with locally advanced uterine cervical squamous cell carcinoma to neoadjuvant chemotherapy.
Shigenori Nanno, Takeshi Fukuda, Takuya Noda, Eijiro Uchikura, Yuichiro Awazu

Mol Clin Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uterine metastasis of lobular breast carcinoma under tamoxifen therapy: A case report.
Yuichiro Awazu, Takeshi Fukuda, Kenji Imai, Makoto Yamauchi, Mari Kasai

Mol Clin Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-box 2 expression is a useful indicator of the response to neoadjuvant chemotherapy for patients with locally advanced uterine cervical squamous cell carcinoma.
Yuta Inoue, Takeshi Fukuda, Shigenori Nanno, Yuichiro Awazu, Masahiro Shimomura

Oncol Lett· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-to-lymphocyte ratio is associated with sensitivity to platinum-based chemotherapy and prognosis in patients with advanced serous ovarian carcinoma.
Takeshi Fukuda, Masaru Kawanishi, Yuichiro Awazu, Shigenori Nanno, Masahiro Shimomura

Mol Clin Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer.
Masahiro Shimomura, Takeshi Fukuda, Yuichiro Awazu, Shigenori Nanno, Yuta Inoue

Oncol Lett· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRMT1 expression predicts sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma.
Hiroaki Matsubara, Takeshi Fukuda, Yuichiro Awazu, Shigenori Nanno, Masahiro Shimomura

Oncol Lett· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis